MedTrace Logo

Individual Approach for Bowel Preparation Before Colonoscopy

NCT01476735 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2018-04-06

No results posted yet for this study

Summary

This is a prospective, randomized, single-blind study designed to evaluate the influence of individual approach on bowel preparation quality for colonoscopy. The investigators compare split-dose polyethylene glycol solution (PEG, Fortrans, Beaufour Ipsen) to modified split-dose PEG regarding predictors of inadequate preparation for colonoscopy.

Conditions

  • Split-dose Bowel Preparation
  • Polyethylene Glycol Solution
  • Risk Factors Inadequate Preparation

Interventions

OTHER

individual preparation for colonoscopy

The volume of polyethylene glycol solution depends on risk factors presented in each patient. Time of administration of second dose will be confirmed according to the time of colonoscopy. In case of constipation an enema before colonoscopy will be administered. All patients will give educational booklet of preparation before colonoscopy

Sponsors & Collaborators

  • Maria Sklodowska-Curie National Research Institute of Oncology

    lead OTHER

Principal Investigators

  • Jaroslaw Regula, MD, PhD · Maria Sklodowska-Curie Memorial cancer Center, Institute of Oncology, Warsaw, Poland

  • Michal F. Kaminski, MD · Maria Sklodowska-Curie Memorial cancer Center, Institute of Oncology, Warsaw, Poland

  • Dorota Wretowska, MD · Maria Sklodowska-Curie Memorial cancer Center, Institute of Oncology, Warsaw, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-12-31
Completion
2013-03-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01476735 on ClinicalTrials.gov